UGT2B15 and polycystic ovary syndrome: Furthermore, we provided evidence that (R)/(S)-NAF, acting as UGT2B15 inducers, alleviates PCOS-like symptoms in mice, emphasizing the therapeutic promise of targeting UGT2B15 in managing PCOS.